×
About 17,928 results

No Benefit to Intensifying Diabetes Meds at Hospital Discharge
https://www.medpagetoday.com/primarycare/diabetes/95187

Oct 21st, 2021 - Some older folks discharged from the hospital left with a more intense -- and possibly unnecessary -- treatment regimen for their diabetes, according to findings from the VA health system. In a retrospective study of over 28,000 patients ages 65 and older with type 2 diabetes, about 11% were discharged with an intensified regimen, which seemed to yield a mixed bag of outcomes, as these patients...

Ivermectin for COVID-19 Linked to Severe Toxicity in Small Study
https://www.medpagetoday.com/infectiousdisease/covid19/95162

Oct 20th, 2021 - Ivermectin taken to prevent or treat COVID-19 led to toxic effects, including severe episodes of confusion, ataxia, seizures, and hypotension, a small observational study showed. Of 21 callers to the Oregon Poison Center in August -- including 11 people who said they used ivermectin to prevent COVID-19 and 10 who used the drug to treat COVID symptoms -- six were hospitalized for toxic effects f...

FDA Looks Closer at Myocarditis; Cognition and DOACs; Silver Lining of Lockdowns?
https://www.medpagetoday.com/cardiology/prevention/95128

Oct 19th, 2021 - The American Heart Association warns that progress is slowing in national care for ST-segment elevation myocardial infarction. (Circulation) FDA's internal deliberations on myocarditis risk will delay its decision on authorizing the Moderna COVID-19 vaccine for adolescents. (Wall Street Journal) Takotsubo syndrome disproportionately affects older women in the U.S., though its incidence is risin...

B-Cell Targeted Therapy Linked With Severe COVID-19 Among Patients With Arthritis
https://www.medscape.com/viewarticle/960498

Oct 11th, 2021 - NEW YORK (Reuters Health) - In patients with inflammatory arthritis (IA), B-cell-targeted therapy is linked with severe COVID-19, a new study from France shows. "These results strongly indicate the increased risk of severe COVID-19 in patients receiving B-cell targeted therapy. Among patients with IA, those receiving rituximab should be prioritised for vaccination against SARS-CoV-2, sufficient...

Can the Death Rattle Be Silenced?
https://www.medpagetoday.com/geriatrics/generalgeriatrics/94857

Oct 5th, 2021 - Prophylactic anticholinergic dosing once death was imminent in hospice patients reduced death rattle, the SILENCE trial showed. Subcutaneous scopolamine butylbromide (which is not FDA approved) cut the incidence of grade 2 or greater noisy breathing from mucus in the respiratory tract to 13% compared with 27% with placebo (P=0.02). Time from recognition that the patient was in the active dying ...

Brazil Hospital Chain Hid COVID-19 Deaths, Whistleblowers' Lawyer Tells Senate
https://www.medscape.com/viewarticle/959912

Sep 29th, 2021 - BRASILIA (Reuters) - A Brazilian hospital chain tested unproven drugs on elderly COVID-19 patients without their knowledge as part of an effort to validate President Jair Bolsonaro's preferred 'miracle cure,' a lawyer for whistleblowing doctors told senators on Tuesday. At least nine people died of COVID-19 during the trials at the Prevent Senior hospital chain from March to April 2020, but the...

Ground-breaking EEG Test Could Diagnose Alzheimer’s Disease 5 Years Earlier
https://www.medscape.com/viewarticle/959752

Sep 27th, 2021 - Researchers at the University of Bath have developed a ground-breaking simple two-minute test which could allow Alzheimer’s disease to be diagnosed five years earlier than with current methods. The ground-breaking Fastball EEG test could pave the way for improved outcomes for patients with Alzheimer’s disease by diagnosing the condition earlier, allowing treatments to be initiated before signif...

Preventing Gun Violence in Patients With Dementia
https://www.medpagetoday.com/geriatrics/dementia/94663

Sep 23rd, 2021 - Ways to reduce the risk of violence from firearms by people with dementia were described during a webinar hosted earlier this week by the BulletPoints Project, an initiative that was authorized and funded by California's state legislature in collaboration with the University of California. Five million Americans, or 1.6% of the population, have Alzheimer's dementia or related dementias. This nu...

Association of Ophthalmic and Systemic Conditions with Dementia Risk
https://www.medscape.com/viewarticle/959295

Sep 23rd, 2021 - Takeaway Ophthalmic conditions, including age-related macular degeneration (AMD), cataract and diabetes-related eye disease (DRED), but not glaucoma, were associated with an increased risk of incident dementia. Individuals with both ophthalmic and systemic conditions had a higher risk of dementia compared with those with an ophthalmic or systemic condition alone. Why this matters Findings sugge...

Portico Hits the Market; TAVR Explantation Risks; Beware Unreliable Registries?
https://www.medpagetoday.com/cardiology/prevention/94604

Sep 20th, 2021 - German recipients of the AstraZeneca COVID-19 vaccine showed that severe headache can precede cerebral venous sinus thrombosis by a few days in vaccine-induced immune thrombotic thrombocytopenia (VITT), according to a brief report in the New England Journal of Medicine. Hospitals with multidisciplinary cardiogenic shock teams performed better in shock management and cardiac ICU survival. (Journ...

Support for ECT in Severely Depressed Older Adults
https://www.medscape.com/viewarticle/958950

Sep 20th, 2021 - NEW YORK (Reuters Health) - Electroconvulsive therapy (ECT) is associated with lower risk of death over one year, as well as short-lived protective effects on suicide risk, in older adults hospitalized with a mood disorder, according to results of an observational study. "ECT is not a panacea, but when used appropriately and safely, it may be effective in reducing suicidality in adults with sev...

Countries Weigh Need for Booster COVID-19 Shots
https://www.medscape.com/viewarticle/958690

Sep 15th, 2021 - Sept 14 (Reuters) - COVID-19 vaccine booster shots will be made widely available to Americans this month, while several other countries including Britain, Israel, Germany and France, have decided to offer boosters to older adults and people with weak immune systems. There is no consensus yet among scientists and agencies that a third dose is necessary. The World Health Organization (WHO) said o...

Aging Cancer Survivors Have Greater Functional Decline
https://www.medscape.com/viewarticle/958289

Sep 8th, 2021 - (Reuters Health) - Older adults who are cancer survivors may experience more rapid functional decline than peers without a history of cancer, a recent study suggests. Researchers examined data on 1,728 adults aged 22 to 100 years who participated in the Baltimore Longitudinal Study of Aging and underwent functional status evaluations including tests of grip strength, gait speed, and overall phy...

Antihypertensive Therapy and COVID-19 Outcomes in Middle-aged and Older Adults
https://www.medscape.com/viewarticle/958034

Sep 2nd, 2021 - Takeaway The use of angiotensin-converting enzyme inhibitors (ACEI) was associated with an increased risk of COVID-19-related mortality and the use of calcium channel blockers (CCB) was associated with a lower risk of COVID-19-related hospitalisation in men. The use of angiotensin-receptor blockers (ARB) was associated with a lower risk of COVID-19-related mortality in women. Why this matters F...

Brazil to Give COVID-19 Booster Shots to Elderly and Vulnerable
https://www.medscape.com/viewarticle/957216

Aug 26th, 2021 - SAO PAULO (Reuters) - Brazil will give booster shots of COVID-19 vaccines to people with compromised immune systems and those over the age of 70 beginning in mid-September, the Health Ministry said on Wednesday. Vaccines from AstraZeneca, Johnson & Johnson, or Pfizer will be used for the booster shots, the ministry said in a statement. The information differs from remarks on Tuesday by Health M...

Countries Weigh Need for Booster COVID-19 Shots
https://www.medscape.com/viewarticle/957105

Aug 25th, 2021 - Aug 24 (Reuters) - COVID-19 vaccine booster shots will be made widely available to Americans in September, while several other countries including Israel, Germany and France have decided to offer boosters to older adults and people with weak immune systems. As of yet, there is no consensus among scientists and agencies that a third dose is necessary. The World Health Organization (WHO) said on ...

Israel Finds COVID-19 Vaccine Booster Significantly Lowers Infection Risk
https://www.medscape.com/viewarticle/957030

Aug 24th, 2021 - JERUSALEM (Reuters) - A third dose of Pfizer COVID-19 vaccine has significantly improved protection from infection and serious illness among people aged 60 and older in Israel compared with those who received two shots, findings published by the Health Ministry showed on Sunday. The data were presented at a meeting of a ministry panel of vaccination experts on Thursday and uploaded to its websi...

Prevalence of Homebound Older Adults in US Rose Dramatically With Pandemic
https://www.medscape.com/viewarticle/957072

Aug 24th, 2021 - (Reuters Health) - The number of homebound seniors nearly tripled between 2019 and 2020 with the biggest increases seen among Hispanic and Black Americans, a U.S. study finds. In an analysis of data from the National Health and Aging Trends Study (NHATS), researchers estimate that in 2019 there were 1.6 million seniors aged 70 or older who left home once a week or less often, as compared to 4.2...

Israeli Doctors Find Severe COVID-19 Breakthrough Cases Mostly in Older, Sicker Patients
https://www.medscape.com/viewarticle/956960

Aug 23rd, 2021 - JERUSALEM (Reuters) - In Israel's COVID-19 wards, doctors are learning which vaccinated patients are most vulnerable to severe illness, amid growing concerns about instances in which the shots provide less protection against the worst forms of the disease. Around half of the country's 600 patients presently hospitalized with severe illness have received two doses of the Pfizer Inc shot, a rare ...

Pictures of Diseased Arteries Spur Action on Lipid Lowering
https://www.medpagetoday.com/cardiology/prevention/94117

Aug 19th, 2021 - Prescribing behavior in primary care changed when patients were shown information about their narrowing arteries in picture form, according to a secondary analysis of the VIPVIZA trial. People randomized to receive a simplified pictorial presentation of their carotid ultrasonography results -- plus a follow-up call from a nurse to answer any questions about the information -- were more likely t...